Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.
暂无分享,去创建一个
S. Pocock | G. Stone | T. Henry | A. Kirtane | M. Krucoff | G. Dangas | G. Weisz | R. Mehran | A. Kini | U. Baber | A. Colombo | D. Cohen | C. Gibson | P. Steg | D. Moliterno | S. Sartori | B. Witzenbichler | G. Giustino | A. Chieffo | C. Ariti | Claire Litherland | Mitchell W. Krucoff | D. Cohen | Timothy D. Henry | D. Cohen | David J. Cohen | Ajay J. Kirtane | G. Stone | C. Gibson | P. Steg
[1] J. Spertus,et al. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. , 2016, JAMA.
[2] Peter L Duffy,et al. Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. , 2015, Journal of the American College of Cardiology.
[3] Samin K. Sharma,et al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. , 2015, Journal of the American College of Cardiology.
[4] R. Mehran,et al. DAPT duration after DES: what is the "mandatory" duration? , 2015, Journal of the American College of Cardiology.
[5] T. Henry,et al. Real-Time Decision Support to Guide Percutaneous Coronary Intervention Bleeding Avoidance Strategies Effectively Changes Practice Patterns , 2014, Circulation. Cardiovascular quality and outcomes.
[6] T. Ryan,et al. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis). , 2014, JACC. Cardiovascular interventions.
[7] Eric D. Peterson,et al. Early Clopidogrel Versus Prasugrel Use Among Contemporary STEMI and NSTEMI Patients in the US: Insights From the National Cardiovascular Data Registry , 2014, Journal of the American Heart Association.
[8] Antonio Colombo,et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study , 2013, The Lancet.
[9] Mandeep Singh,et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. , 2013, JACC. Cardiovascular interventions.
[10] Peter L Duffy,et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study , 2013, The Lancet.
[11] H. White,et al. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. , 2012, JACC. Cardiovascular interventions.
[12] G. Stone,et al. A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score. , 2012, JACC. Cardiovascular interventions.
[13] Deepak L. Bhatt,et al. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting: A North American Perspective: Executive Summary , 2011, Circulation. Cardiovascular interventions.
[14] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.
[15] Gregory Y H Lip,et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.
[16] S. Pocock,et al. A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.
[17] Elizabeth R DeLong,et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. , 2010, Journal of the American College of Cardiology.
[18] Deepak L. Bhatt,et al. Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis , 2010, European heart journal.
[19] Sunil V. Rao,et al. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score , 2009, Circulation.
[20] Frederick A. Masoudi,et al. Evaluating the Evidence: Is There a Rigid Hierarchy? , 2008, Circulation.
[21] Patrick Royston,et al. How should variable selection be performed with multiply imputed data? , 2008, Statistics in medicine.
[22] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[23] B. Gersh,et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. , 2005, Journal of the American College of Cardiology.
[24] R. D'Agostino,et al. Presentation of multivariate data for clinical use: The Framingham Study risk score functions , 2004, Statistics in medicine.
[25] B. Astor,et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). , 2002, Archives of internal medicine.
[26] M. Rich,et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.
[27] E. Antman,et al. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy , 2000, Circulation.
[28] E. Antman,et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.
[29] E W Steyerberg,et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. , 2000, Circulation.
[30] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[31] L. Wallentin,et al. Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). , 2016, European heart journal. Cardiovascular pharmacotherapy.
[32] Lena Osterhagen,et al. Multiple Imputation For Nonresponse In Surveys , 2016 .
[33] J. Alpert,et al. The third universal definition of myocardial infarction , 2013 .